Given the wealth of literature linked MeCP2 to myelin damage in neurological conditions such as Rett Syndrome [53,59,60], it became apparent the importance of conducting similar research studies in other white matter disorders such as MS. The gene discussed is MECP2; the disease is myeloid sarcoma.